LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 2411 | 10473 | 0.2300 | 0.4236 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 1120 | 10473 | 0.1069 | 0.1955 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 737 | 10473 | 0.0703 | 0.0861 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 72 | hr | 513 | 663 | 10473 | 0.0633 | 0.0605 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 694 | 10473 | 0.0663 | 0.0714 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 72 | hr | 513 | 223 | 10473 | 0.0213 | -0.1849 |
MCF 10A | NVP-AEW541 | 0.04 | uM | LJP5 | 72 | hr | 513 | 9731 | 10362 | 0.9390 | 0.9711 |
MCF 10A | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 513 | 8816 | 10362 | 0.8505 | 0.9264 |
MCF 10A | NVP-AEW541 | 0.37 | uM | LJP5 | 72 | hr | 513 | 6000 | 10362 | 0.5783 | 0.7592 |
MCF 10A | NVP-AEW541 | 1.11 | uM | LJP5 | 72 | hr | 513 | 3345 | 10362 | 0.3225 | 0.5387 |
MCF 10A | NVP-AEW541 | 3.33 | uM | LJP5 | 72 | hr | 513 | 3020 | 10362 | 0.2914 | 0.5043 |
MCF 10A | NVP-AEW541 | 10 | uM | LJP5 | 72 | hr | 513 | 1146 | 10362 | 0.1106 | 0.2022 |
MCF 10A | PHA-665752 | 0.04 | uM | LJP5 | 72 | hr | 513 | 9929 | 10362 | 0.9580 | 0.9799 |
MCF 10A | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10091 | 10362 | 0.9738 | 0.9877 |
MCF 10A | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 513 | 9740 | 10362 | 0.9398 | 0.9712 |
MCF 10A | PHA-665752 | 1.11 | uM | LJP5 | 72 | hr | 513 | 9599 | 10362 | 0.9261 | 0.9647 |
MCF 10A | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 513 | 9651 | 10362 | 0.9313 | 0.9674 |
MCF 10A | PHA-665752 | 10 | uM | LJP5 | 72 | hr | 513 | 684 | 10362 | 0.0661 | 0.0614 |
MCF 10A | PI103 | 0.04 | uM | LJP6 | 72 | hr | 513 | 8242 | 10473 | 0.7871 | 0.8928 |
MCF 10A | PI103 | 0.12 | uM | LJP6 | 72 | hr | 513 | 3982 | 10473 | 0.3803 | 0.6003 |
MCF 10A | PI103 | 0.37 | uM | LJP6 | 72 | hr | 513 | 1481 | 10473 | 0.1414 | 0.2746 |
MCF 10A | PI103 | 1.11 | uM | LJP6 | 72 | hr | 513 | 1061 | 10473 | 0.1013 | 0.1789 |
MCF 10A | PI103 | 3.33 | uM | LJP6 | 72 | hr | 513 | 811 | 10473 | 0.0774 | 0.1105 |
MCF 10A | PI103 | 10 | uM | LJP6 | 72 | hr | 513 | 772 | 10473 | 0.0737 | 0.0984 |
MCF 10A | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 9037 | 10362 | 0.8725 | 0.9377 |